Medtronic Receives CE Mark for New Simplera™ CGM with Disposable All-in-one Design
The company’s newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience
Read More
Diabetes
Dexcom ONE Real-time CGM Sensor Launched in France
bringing its highly researched and studied, real-time CGM technology to half a million more people with diabetes in France
Read More
Abbott to Acquire Bigfoot Biomedical to Strengthen Diabetes Care
Acquisition will bring together two leaders in different aspects of diabetes care: CGM and insulin injection support
Read More
Beta Bionics Closes $100 Million Series D Financing to Advance Diabetes Technology
Beta Bionics’ flagship product, the iLet Bionic Pancreas, is an autonomous insulin delivery system that streamlines diabetes management and reduces the burden on patients and physicians
Read More
Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Germany
Omnipod 5 is the first CE marked automated insulin delivery system that integrates with the Dexcom G6 CGM System to automatically adjust insulin delivery and help protect against high and low glucose levels
Read More
Modular Medical and Phillips-Medisize Collaborate to Expand Insulin Delivery Alternatives
Phillips-Medisize will provide Modular Medical with design, development and high-volume manufacturing capabilities
Read More
Nemaura Medical’s sugarBEAT® Approved in Saudi Arabia
Nemaura Medical has received SFDA (Saudi Food and Drug Authority) approval for sugarBEAT®, its non-invasive wearable glucose sensor, after more than a year of liaising with the SFDA
Read More
Welldoc Receives 10th 510(k) Clearance from FDA for BlueStar® Diabetes Platform
New version of the BlueStar® digital health solution available with enhanced insulin dosing capabilities via automatic connected device data
Read More
Dexcom G7 Receives Health Canada Approval for Next-Generation Continuous Glucose Monitoring System
While approved by Health Canada, Dexcom G7 is not yet available for purchase. Dexcom Canada is working diligently to bring Dexcom G7 to Canadians living with diabetes by the end of 2023
Read More
Novo Nordisk to Acquire a Controlling Stake in BICORP for €154M
BIOCORP is a French company specialized in the design, development and manufacturing of delivery systems and innovative medical devices, including Mallya, a Bluetooth enabled smart add-on device for pen injectors
Read More
English (UK) 
简体中文 
Deutsch 
Français 
Español 
Português 
日本語 
Italiano 
Nederlands